Prescription drug · ANDA
Metoprolol Succinate NDC 69097-409
Metoprolol succinate 200 mg/1 · Tablet, Extended release · Oral · Cipla USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69097-409-02 | 69097040902 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-409-02)Marketed from Mar 25, 2019 | |
| 69097-409-07 | 69097040907 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-409-07)Marketed from Mar 25, 2019 | |
| 69097-409-15 | 69097040915 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-409-15)Marketed from Mar 25, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol Succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 200 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Cipla USA Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207465
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 69097-409_95bb3551-0e88-47cc-95e9-35c6dc731fafSPL ID 95bb3551-0e88-47cc-95e9-35c6dc731fafSPL set ID 3a4966a2-2728-4c99-999f-576b3e2df90cRxCUI 866412, 866419, 866436UNII TH25PD4CCBUPC 0369097409074, 0369097407070, 0369097408077
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469097040902followed by a unit qualifier and the quantityPackage 69097-0409-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate extended-release tablets are beta-adrenergic blocker indicated for the treatment of:: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure -, to reduce the risk of cardiovascular mortality and heart failure hospitalization ins patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myoca…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207465
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Cipla USA Inc. | 69097-408 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1686 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6662 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6663 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Cipla USA Inc. | 69097-407 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-9749 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-469 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-470 |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-471 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | NuCare Pharmaceuticals,Inc. | 68071-5282 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Preferred Pharmaceuticals Inc. | 68788-8312 |